Blog Posts

Jan 29, 2025, 10:07

Parth Sharma: The efficacy of HER-2 targeted therapies in biliary tract cancers

Parth Sharma, IM Resident at UMKC Internal Medicine Residency Program, shared on X:

“Thrilled to present our research at ASCOGI25 highlighting the efficacy of HER-2 targeted therapies in biliary tract cancers!!! Grateful to my mentor Marc Roth for his guidance and all the co-authors for their support.“

ASCOGI25 cancer OncoDaily Oncology Parth Sharma

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 13, 2025, 16:18

Udhayvir Grewal: NANETS Guidelines on Management of NEC - A Very Tough-to-Treat Disease

Science

Aug 13, 2025, 16:16

Framework to Select Multi-Cancer Detection Assays for the Vanguard Study - NCI Division of Cancer Prevention

Science

Aug 13, 2025, 15:55

Francesco Massari: Words of Wisdom about nccRCC in European Urology

Science

Aug 13, 2025, 15:48

Myeloma Paper of the Day, August 13th, Suggested by Robert Orlowski

Insight

Aug 13, 2025, 15:36

Dora Vallejo-Ardila: Highlights from First Day of MOGA 2025

Voices

Aug 13, 2025, 15:34

Sameer Keole: Privilege of Being ASTRO President Is Meeting Talented People I’d Not Met Otherwise

Voices

Aug 13, 2025, 15:32

Diana Adams: Medical Oncology Group of Australia (MOGA)⁩ Session on Increasing Workforce Pressure

Voices

Aug 13, 2025, 15:30

Proud to be No.1 in Hypertension and No.6 in Cardiology Worldwide - Servier

Voices

Aug 13, 2025, 15:29

Stefano Magno: Integrative Oncology Teams to Bridge Oncology and Primary Care

Science

Aug 13, 2025, 15:26

Arndt Vogel: Interesting Analysis on Potential Biomarkers to Guide Adjuvant Treatment

Voices

Aug 13, 2025, 15:25

Yvonne Diaz: Survival Rates for the Deadliest Cancers

Insight

Aug 13, 2025, 15:20

Amol Akhade: KEYNOTE-905 - Potential Practice Changer in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer